Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives

Pancreatic cancer is a highly lethal disease, where the mortality closely matches increasing incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type that tends to metastasize early in tumor progression. For metastatic PDAC, gemcitabine had been the mainstay treatment fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Wonhee, Carey, Edward T, Choi, Minsig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391121/
https://www.ncbi.nlm.nih.gov/pubmed/30863113
http://dx.doi.org/10.2147/OTT.S167590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391121/
https://www.ncbi.nlm.nih.gov/pubmed/30863113
http://dx.doi.org/10.2147/OTT.S167590

Ejemplares similares